申请人:Wrobleski Stephen T.
公开号:US20080171741A1
公开(公告)日:2008-07-17
A compound of Formula I
and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase.
公式I的化合物及其对映体、非对映异构体和药学上可接受的盐。还披露了含有公式I化合物的药物组合物,以及治疗与p38激酶活性相关的疾病的方法。